Evidence map›Paper›PMID 25721325›Full record

ArticleCell research2015

A novel chemopreventive strategy based on therapeutic microRNAs produced in plants.

Sizolwenkosi Mlotshwa, Gail J Pruss, John L MacArthur, Matthew W Endres, Celestia Davis, Lorne J Hofseth, Maria Marjorette Peña, Vicki Vance

Registry-linked trialAbstract readLetter
In one paragraph

Article in Cell research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04053569 (Effects of Polyphenols From a Table Grape on the Lipidomic Profile and Serum LDL Fractions), which is not on this map. Cited by 65 papers.

0numbers the graph read from it
0cells of the map it votes in
65citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04053569 naunknown statusnot on this mapstarted 2019, after this paper: background citation

Effects of Polyphenols From a Table Grape on the Lipidomic Profile and Serum LDL Fractions: Possible Implications in the Metabolic Syndrome

TypeinterventionalSponsorAzienda Ospedaliera Specializzata in Gastroenterologia Saverio de BellisRan2019 to 2022Enrolled40ConditionsMetabolic Syndrome, Protection AgainstArmsTable Grape supplement
3 · Its place in the literature

Who cites it

65 citing papers in PubMed.

  1. Review
  2. Article
  3. Human miRNAs in Cancer: Statistical Trends and Cross Kingdom Approach.International journal of molecular sciences · 2025
    Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. Plant-derived xenomiRs and cancer: Cross-kingdom gene regulation.Saudi journal of biological sciences · 2021
    Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Review

5 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Sizolwenkosi MlotshwaDepartment of Biological Sciences, University of South Carolina, Columbia, SC 29208, USA;
Gail J PrussDepartment of Biological Sciences, University of South Carolina, Columbia, SC 29208, USA;
John L MacArthurDepartment of Biological Sciences, University of South Carolina, Columbia, SC 29208, USA;
Matthew W EndresDepartment of Biological Sciences, University of South Carolina, Columbia, SC 29208, USA;
Celestia DavisDepartment of Biological Sciences, University of South Carolina, Columbia, SC 29208, USA;
Lorne J HofsethDepartment of Drug Discovery and Biomedical Sciences, South Carolina College of Pharmacy, University of South Carolina, Columbia, SC 29208, USA.
Maria Marjorette PeñaDepartment of Biological Sciences, University of South Carolina, Columbia, SC 29208, USA;
Vicki VanceDepartment of Biological Sciences, University of South Carolina, Columbia, SC 29208, USA;

Funding

Targeting early ceramide elevation in pre-symptomatic eczemaP20GM103641 · NIGMS · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI ENOS, REILLY, NAGARKATTI, PRAKASH S · 2012 to 2023
$20.7M
Use of Resveratrol to treat experimental multiple sclerosisP01AT003961 · NCCIH · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI NAGARKATTI, PRAKASH S · 2007 to 2018
$14.2M
TISSUE BIOREPOSITORY COREP30GM103336 · NIGMS · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI BERGER, FRANKLIN G. · 2013 to 2017
$5.4M
Targeting Protein Arginine Deiminases to Prevent Colitis and Colon CancerR01CA151304 · NCI · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI HOFSETH, LORNE J, THOMPSON, PAUL R · 2011 to 2015
$1.6M
Stromal modulation of response to Thymidylate synthase inhibitorsR01CA154731 · NCI · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI PENA, MARIA MARJORETTE · 2011 to 2015
$1.5M
A Chemopreventive Strategy Based on Edible MicroRNAs Produced in PlantsR03CA181895 · NCI · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI VANCE, VICKI · 2014 to 2015
$147k
NCCIH NIH HHS P01 AT003961NCI NIH HHS 1R03CA181895-01A1NCI NIH HHS 5R01CA151304NCI NIH HHS 5R01CA154731-04NCI NIH HHS R01 CA151304NCI NIH HHS R01 CA154731NCI NIH HHS R03 CA181895NIGMS NIH HHS 5P30 GM103336-02NIGMS NIH HHS P20 GM103641NIGMS NIH HHS P30 GM103336
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Gene Transfer TechniquesAdministration, OralAnimalsColonic NeoplasmsDisease Models, AnimalGenes, Tumor SuppressorGenetic TherapyMicroRNAsPlantsMicroRNAs

Identifiers

PMID25721325
PMCPMC4387556

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.